Jun Zhang

ORCID: 0000-0001-6990-5324
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Lung Cancer Treatments and Mutations
  • Cancer Genomics and Diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Liver Disease Diagnosis and Treatment
  • RNA modifications and cancer
  • Immune Cell Function and Interaction
  • Pediatric Hepatobiliary Diseases and Treatments
  • PI3K/AKT/mTOR signaling in cancer
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Mesenchymal stem cell research
  • Epigenetics and DNA Methylation
  • Gastric Cancer Management and Outcomes
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer-related molecular mechanisms research
  • Genetic factors in colorectal cancer
  • Glioma Diagnosis and Treatment
  • Immune Response and Inflammation
  • Cancer-related gene regulation
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Hypoxia, and Metabolism
  • T-cell and B-cell Immunology
  • Autoimmune Neurological Disorders and Treatments

First Affiliated Hospital of Jiangxi Medical College
2025

Jiangxi Provincial People's Hospital
2025

Peking University
2013-2025

Huashan Hospital
2014-2025

Yangzhou University
2025

Suzhou Municipal Hospital
2025

Nanjing Medical University
2016-2025

Lu'an First People's Hospital
2025

Anhui Medical University
2016-2025

Fudan University
2014-2025

Liver mass depends on one or more unidentified humoral signals that drive regeneration when liver functional capacity is diminished. Bile acids are important products, and their levels tightly regulated. Here, we identify a role for nuclear receptor-dependent bile acid signaling in normal regeneration. Elevated accelerate regeneration, decreased inhibit regrowth, as does the absence of primary receptor FXR. We propose FXR activation by increased flux signal liver. FXR, possibly other...

10.1126/science.1121435 article EN Science 2006-04-13

Objective A close relationship between gut microbiota and some chronic liver disorders has recently been described. Herein, we systematically performed a comparative analysis of the microbiome in primary biliary cholangitis (PBC) healthy controls. Design We first conducted cross-sectional study 60 ursodeoxycholic acid (UDCA) treatment-naïve patients with PBC 80 matched Second, an independent cohort composed 19 34 controls was used to validate results. Finally, prospective subgroup 37 who...

10.1136/gutjnl-2016-313332 article EN Gut 2017-02-17

Objective The significance of the liver-microbiome axis has been increasingly recognised as a major modulator autoimmunity. aim this study was to take advantage large well-defined corticosteroids treatment-naïve group patients with autoimmune hepatitis (AIH) rigorously characterise gut dysbiosis compared healthy controls. Design We performed cross-sectional individuals AIH (n=91) and matched controls (n=98) by 16S rRNA gene sequencing. An independent cohort 28 34 analysed validate results....

10.1136/gutjnl-2018-317836 article EN Gut 2019-06-14

The constitutive androstane receptor (CAR, NR1I3) is a central regulator of xenobiotic metabolism. CAR activation induces hepatic expression detoxification enzymes and transporters increases liver size. Here we show that CAR-mediated hepatomegaly transient, adaptive response to acute stress. In contrast, chronic results in hepatocarcinogenesis. both responses, hepatocyte DNA replication increased apoptosis decreased. These effects are absent null mice, which completely resistant tumorigenic...

10.1210/me.2004-0520 article EN Molecular Endocrinology 2005-04-15

As part of a large scale effort to discover novel secreted proteins, cDNA encoding cytokine was identified. Alignments the sequence new protein, designated IL-17B, suggest it be homolog recently described T cell-derived cytokine, IL-17. By Northern analysis, EST distribution and real-time quantitative polymerase chain reaction mRNA detected in many cell types. A type I transmembrane identified an data base by homology IL-17R, found bind specifically as determined surface plasmon resonance...

10.1074/jbc.m910228199 article EN cc-by Journal of Biological Chemistry 2000-06-01

Abstract BACKGROUND Vascular endothelial growth factor (VEGF) is a critical proangiogenic in solid tumors. However, its expression and role human neuroendocrine tumor development progression remains unclear. METHODS Using immunohistochemistry, VEGF Sp1 patterns were investigated 50 cases of gastrointestinal having various clinicopathologic characteristics. RESULTS It was found that strong detected cells, whereas no or very weak stromal cells surrounding within the The levels directly...

10.1002/cncr.22554 article EN Cancer 2007-03-05

Genetic mutation and pharmacological inhibition of Bruton9s tyrosine kinase (Btk) both have been shown to prevent the development collagen-induced arthritis (CIA) in mice, providing a rationale for Btk inhibitors treating rheumatoid (RA). In present study, we characterized novel inhibitor, 6-cyclopropyl-8-fluoro-2-(2-hydroxymethyl-3-{1-methyl-5-[5-(4-methyl-piperazin-1-yl)-pyridin-2-ylamino]-6-oxo-1,6-dihydro-pyridin-3-yl}-phenyl)-2<i>H</i>-isoquinolin-1-one (RN486), vitro rodent models...

10.1124/jpet.111.187740 article EN Journal of Pharmacology and Experimental Therapeutics 2012-01-06

Sphingosine-1-phosphate (S1P) is a bioactive lipid that regulates multicellular functions through interactions with its receptors on cell surfaces. S1P enriched and stored in erythrocytes; however, it not clear whether alterations are involved the prevalent debilitating hemolytic disorder sickle disease (SCD). Here, using metabolomic screening, we found highly elevated blood of mice humans SCD. In murine models SCD, demonstrated erythrocyte sphingosine kinase 1 (SPHK1) underlies sickling...

10.1172/jci74604 article EN Journal of Clinical Investigation 2014-05-15

Purpose: B-cell lymphoma-2 (BCL-2), an antiapoptotic protein often dysregulated in lymphomas, promotes cell survival and provides protection from stress. A recent phase I first-in-human study of the BCL-2 inhibitor venetoclax non-Hodgkin lymphoma showed overall response rate 44%. These promising clinical results prompted our examination biological effects mechanism action underlying activity aggressive lymphoma, including mantle (MCL) diffuse large (DLBCL).Experimental Design: MCL DLBCL...

10.1158/1078-0432.ccr-17-3004 article EN Clinical Cancer Research 2018-04-17

Multiple clinical similarities exist between IgG4-related sclerosing cholangitis (IgG4-SC) and primary (PSC), while gut dysbiosis has been extensively studied in PSC, the role of microbiota IgG4-SC remains unknown. Herein, we aimed to evaluate alterations microbiome metabolome PSC.We performed 16S rRNA gene amplicon sequencing faecal samples from 135 subjects with (n=34), PSC (n=37) healthy controls (n=64). A subset (31 IgG4-SC, 37 45 controls) also underwent untargeted metabolomic...

10.1136/gutjnl-2020-323565 article EN Gut 2021-05-25

Proximal spinal muscular atrophy (SMA), one of the most common genetic causes infant death, results from selective loss motor neurons in cord. SMA is a consequence low levels survival neuron (SMN) protein. In humans, SMN gene duplicated; SMN1 but SMN2 remains intact. severity related to copy number SMN2. Compounds which increase expression could, therefore, be potential therapeutics for SMA. Ultrahigh-throughput screening recently identified substituted quinazolines as potent inducers. A...

10.1093/hmg/ddp510 article EN Human Molecular Genetics 2009-11-06

Multiple sclerosis (MS) is an irreversible and demyelinating disease of the central nervous system, in part influenced by chronic inflammation. There no proven effective therapy to stop pathological progression MS, although suppressing immune system control inflammatory response may improve clinical performance acutely. Here, we found that mesenchymal stem cells from human umbilical cord (hUC-MSCs) could restore behavioral functions attenuate histopathological deficits experimental...

10.1089/scd.2012.0463 article EN Stem Cells and Development 2012-11-09

The serologic hallmark of primary biliary cirrhosis (PBC), the antimitochondrial response to E2 component pyruvate dehydrogenase complex (PDC-E2), has unique features, including continuous high titers immunoglobulin M (IgM) and IgG reactivity throughout all stages disease, capable not only target enzyme inhibition, but also crossreactive with chemical xenobiotics that share molecular homology inner lipoyl domain PDC-E2; such chemicals have been proposed as potential etiological agents. We...

10.1002/hep.27313 article EN Hepatology 2014-07-15

Summary Fedratinib, an oral Janus kinase‐2 (JAK2) inhibitor, reduces splenomegaly and improves symptom burden in patients with myelofibrosis. Regulatory approval of fedratinib 400‐mg daily was based on results updated analysis the pivotal phase III, placebo‐controlled JAKARTA trial JAK‐inhibitor‐naïve At week 24, spleen volume response rate 47% 40% 400 mg, versus 1% 9% respectively, placebo. Common adverse events were diarrhoea, nausea, anaemia, vomiting. No Wernicke encephalopathy occurred...

10.1111/bjh.17727 article EN cc-by-nc British Journal of Haematology 2021-07-30

Background: Increasing data suggests an interaction between bile acids and intestinal microbiota in the pathogenesis of primary biliary cholangitis (PBC). Bile acid sequestrants are widely used to bind lumen therefore posited impact gut bacteria. Herein we aimed investigate effects cholestyramine on profile microbiome a cohort icteric PBC patients.Results: Thirty-three patients were treated with cholestyramine, serum stool samples collected at baseline, 4 16 weeks. Shotgun metagenomic...

10.1080/19490976.2021.1946366 article EN cc-by Gut Microbes 2021-01-01

PTEN loss has been associated with poorer prognosis in many solid tumors. However, such investigation lymphomas is limited. In this study, cytoplasmic and nuclear expression, gene deletion, mutations were evaluated two independent cohorts of diffuse large B-cell lymphoma (DLBCL). Cytoplasmic expression was found approximately 67% total 747 DLBCL cases, more frequently the activated B-cell–like subtype. Nuclear less frequent at lower levels, which significantly correlated higher mRNA...

10.1016/j.neo.2018.03.002 article EN cc-by-nc-nd Neoplasia 2018-05-04
Coming Soon ...